皮肤基底细胞癌与鳞状细胞癌的根治性与术后放疗:ASTRO临床实践指南执行摘要
美国放射肿瘤学会(ASTRO)基于系统文献综述与预设共识方法,针对皮肤基底细胞癌(BCC)和皮肤鳞状细胞癌(cSCC)的根治性与术后放疗适应症、剂量分割、靶区、计划设计、放疗模态及联合系统治疗等5个关键问题制定推荐。指南推荐根治性放疗作为非手术候选者的主要治疗,条件性推荐用于充分切除后美容或功能结果不佳者,并建议不要卡铂同步辅助放疗。
要点
- 根治性放疗推荐用于非手术候选的BCC和cSCC患者。
- 充分切除后美容或功能结果不佳时条件性推荐放疗,强调共同决策。
- 不建议卡铂同步辅助放疗;不可切除原发灶可条件性推荐系统治疗。
核心结论
- 指南为BCC和cSCC的根治性与术后放疗提供基于现有证据的实践推荐,并指出高质量证据缺乏。
研究设计与样本
- ASTRO召集专项工作组,基于系统文献综述和预设共识构建方法及证据质量与推荐强度分级系统制定指南。
主要发现
- 指南针对5个关键问题提供推荐,包括根治性与术后放疗适应症、剂量分割方案、靶区、治疗计划基本方面、放疗模态选择及系统治疗联合放疗的作用。
- 术后放疗适应症在充分切除后提供若干条,并区分BCC与cSCC的推荐强度。
- 工作组为根治性和术后场景的原发灶及淋巴结体积建议了一系列适当的剂量分割方案。
关键数值与推荐
- 根治性放疗推荐作为非手术候选BCC和cSCC患者的主要治疗。
- 条件性推荐放疗用于充分切除可能导致美容或功能结果不理想的情况,强调共同决策。
- 不建议卡铂同步辅助放疗。
- 条件性推荐系统治疗用于可能需要升级治疗的不可切除原发灶。
- 一个关键问题专门定义区域淋巴结照射的适应症。
临床怎么用
- 临床应根据患者手术候选状态、切除后美容功能预期及疾病分期,参考指南推荐选择根治性或术后放疗。
- 放疗计划应参考指南建议的剂量分割方案和靶区定义,并注意不推荐卡铂同步辅助放疗。
- 鼓励将患者纳入前瞻性试验,并尽可能以多学科方式管理。
局限性
- 定义放疗在BCC和cSCC管理中的作用受限于缺乏高质量证据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: This guideline reviews the evidence for the use of definitive and postoperative radiation therapy (RT) in patients with basal cell carcinoma (BCC) and cutaneous squamous cell carcinoma (cSCC). METHODS: The American Society for Radiation Oncology convened a task force to address 5 key questions focused on indications for RT in the definitive and postoperative setting for BCC and cSCC, as well as dose-fractionation schemes, target volumes, basic aspects of treatment planning, choice of radiation modality, and the role of systemic therapy in combination with radiation. Recommendations were based on a systematic literature review and created using a predefined consensus-building methodology and system for grading evidence quality and recommendation strength. RESULTS: The guideline recommends definitive RT as primary treatment for patients with BCC and cSCC who are not surgical candidates while conditionally recommending RT with an emphasis on shared decision-making in those situations in which adequate resection can lead to a less than satisfactory cosmetic or functional outcome. In the postoperative setting, a number of indications for RT after an adequate resection are provided while distinguishing the strength of the recommendations between BCC and cSCC. One key question is dedicated to defining indications for regional nodal irradiation. The task force suggests a range of appropriate dose-fractionation schemes for treatment of primary and nodal volumes in definitive and postoperative scenarios. The guideline also recommends against the use of carboplatin concurrently with adjuvant RT and conditionally recommends the use of systemic therapies for unresectable primaries where treatment may need escalation. CONCLUSIONS: Defining the role of RT in the management of BCC and cSCC has been hindered by a lack of high-quality evidence. This document synthesizes available evidence to define practice guidelines for the most common clinical situations. We encourage practitioners to enroll patients in prospective trials and to approach care in a multidisciplinary fashion whenever possible.
引用
- Likhacheva A, Awan M, Barker CA, et al. Definitive and Postoperative Radiation Therapy for Basal and Squamous Cell Cancers of the Skin: Executive Summary of an American Society for Radiation Oncology Clinical Practice Guideline. Pract Radiat Oncol. 2019. PMID: 31831330. doi:10.1016/j.prro.2019.10.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。